NZ192453A - N-aryl-n-(2-imidazoldinylidene)-urea compounds - Google Patents

N-aryl-n-(2-imidazoldinylidene)-urea compounds

Info

Publication number
NZ192453A
NZ192453A NZ192453A NZ19245379A NZ192453A NZ 192453 A NZ192453 A NZ 192453A NZ 192453 A NZ192453 A NZ 192453A NZ 19245379 A NZ19245379 A NZ 19245379A NZ 192453 A NZ192453 A NZ 192453A
Authority
NZ
New Zealand
Prior art keywords
imidazoldinylidene
aryl
urea compounds
urea
compounds
Prior art date
Application number
NZ192453A
Other languages
English (en)
Inventor
C Rasmussen
Original Assignee
Mcneilab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/972,579 external-priority patent/US4229462A/en
Priority claimed from US05/972,580 external-priority patent/US4239768A/en
Application filed by Mcneilab Inc filed Critical Mcneilab Inc
Publication of NZ192453A publication Critical patent/NZ192453A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/30Isothioureas
    • C07C335/38Isothioureas containing any of the groups, X being a hetero atom, Y being any atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30Oxygen or sulfur atoms
    • C07D233/42Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NZ192453A 1978-12-22 1979-12-18 N-aryl-n-(2-imidazoldinylidene)-urea compounds NZ192453A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/972,579 US4229462A (en) 1978-12-22 1978-12-22 Method for controlling hypertension and compositions
US05/972,580 US4239768A (en) 1978-12-22 1978-12-22 Method for relieving irritable bowel syndrome symptoms

Publications (1)

Publication Number Publication Date
NZ192453A true NZ192453A (en) 1982-09-07

Family

ID=27130555

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ192453A NZ192453A (en) 1978-12-22 1979-12-18 N-aryl-n-(2-imidazoldinylidene)-urea compounds

Country Status (23)

Country Link
AT (1) AT373878B (fi)
AU (2) AU532332B2 (fi)
CA (1) CA1127651A (fi)
CH (1) CH647236A5 (fi)
DE (1) DE2951213A1 (fi)
DK (1) DK548179A (fi)
ES (1) ES487159A0 (fi)
FI (1) FI66354C (fi)
FR (2) FR2444462B1 (fi)
GB (2) GB2040681B (fi)
GR (1) GR68018B (fi)
HU (1) HU183013B (fi)
IL (1) IL59019A (fi)
IT (1) IT1126839B (fi)
NL (1) NL7909265A (fi)
NO (1) NO794249L (fi)
NZ (1) NZ192453A (fi)
PH (1) PH16571A (fi)
PT (1) PT70624A (fi)
SE (1) SE7910612L (fi)
SU (1) SU971098A3 (fi)
YU (1) YU314979A (fi)
ZW (1) ZW25379A1 (fi)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4673680A (en) * 1985-09-18 1987-06-16 Pendleton Robert G α2 -adrenergic receptor antagonists as modifiers of gastrointestinal motility
US11516649B2 (en) * 2018-10-29 2022-11-29 Apple Inc. Mechanism to activate and manage a standalone device for cellular service

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1296962A (fr) * 1960-08-05 1962-06-22 Geigy Ag J R Nouveaux composés 2-imino-1.3-di-aza et leur préparation
NL267923A (fi) * 1960-08-05

Also Published As

Publication number Publication date
CA1127651A (en) 1982-07-13
CH647236A5 (de) 1985-01-15
IL59019A (en) 1984-05-31
IL59019A0 (en) 1980-03-31
NL7909265A (nl) 1980-06-24
FR2444462B1 (fr) 1986-08-29
FR2445321A1 (fi) 1980-07-25
AU5378079A (en) 1980-06-26
AU532332B2 (en) 1983-09-29
FI66354B (fi) 1984-06-29
GB2113204B (en) 1984-02-01
FR2444462A1 (fr) 1980-07-18
IT7951164A0 (it) 1979-12-21
YU314979A (en) 1983-02-28
PT70624A (en) 1980-01-01
AT373878B (de) 1984-02-27
DE2951213A1 (de) 1980-07-10
NO794249L (no) 1980-06-24
PH16571A (en) 1983-11-18
GB2040681A (en) 1980-09-03
ES8101558A1 (es) 1980-12-16
FI66354C (fi) 1984-10-10
AU1640083A (en) 1983-11-17
HU183013B (en) 1984-04-28
FR2445321B1 (fi) 1983-08-26
FI794036A (fi) 1980-06-23
GR68018B (fi) 1981-10-27
SU971098A3 (ru) 1982-10-30
SE7910612L (sv) 1980-06-23
GB2113204A (en) 1983-08-03
DK548179A (da) 1980-06-23
GB2040681B (en) 1983-04-13
ZW25379A1 (en) 1981-07-22
ATA808979A (de) 1983-07-15
IT1126839B (it) 1986-05-21
AU566013B2 (en) 1987-10-08
ES487159A0 (es) 1980-12-16

Similar Documents

Publication Publication Date Title
EG13913A (en) Novel n-heterocyclyl-4-piperidinamines
JPS54119486A (en) 66substituted thiaaaza compound
JPS5592393A (en) Aminoorganosiliconacylamino compound
GB2025666B (en) Case for atimepiece
GB2025999B (en) Bistrialkoxysiloxy - silane compound
PH14716A (en) 3-substituted-5-vinyl-2-pyrrolidone compounds
GB2031425B (en) 3-unsubstituted-3-cephem compounds
JPS54163582A (en) 22phenoxyy55 trifluoromethypiridine compound
JPS54138524A (en) Boronnsilicon compound
JPS54160397A (en) Antiirhinouiruse compound
GB2020279B (en) Piperazinylbenzoheterocyclic compounds
JPS54138522A (en) Sulfonateeorganosilanol compound
ZA792633B (en) Flukicidal compounds
JPS54128538A (en) 44nitroo22trichlormethyllphenyldisulfide compound
JPS5536471A (en) Spiroketaline compound
JPS54141766A (en) Antiiinflammatory compound
JPS54125625A (en) 33hydroxybenzyl compound
JPS5559193A (en) Bblactam compound
IL56814A (en) 2-decarboxy-2-alkylcarbonyl-prostaglandin compounds
JPS554400A (en) Hindereddphenol compound
JPS5553271A (en) Novel acylaminoo1*44dihydropyridine compound
GB2021680B (en) Latch-and-keeper mechanisms
PH15905A (en) Furonaphthyridine compounds
ZA791714B (en) Piperazinylbenzoheterocyclic compounds
JPS54151989A (en) 44pyrimidylsulfide compound